• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于居住安排的糖尿病患者强化血糖和血压控制对心血管事件的异质性影响。

Heterogeneous Effects of Intensive Glycemic and Blood Pressure on Cardiovascular Events Among Diabetes by Living Arrangements.

机构信息

Department of Social Epidemiology Graduate School of Medicine Kyoto University Kyoto Japan.

Department of Preventive Services Kyoto University School of Public Health Kyoto Japan.

出版信息

J Am Heart Assoc. 2024 Jul 2;13(13):e033860. doi: 10.1161/JAHA.123.033860. Epub 2024 Jun 27.

DOI:10.1161/JAHA.123.033860
PMID:38934867
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11255686/
Abstract

BACKGROUND

Although living alone versus with others is a key social element for cardiovascular prevention in diabetes, evidence is lacking about whether the benefit of intensive glycemic and blood pressure (BP) control differs by living arrangements. We thus aim to investigate heterogeneity in the joint effect of intensive glycemic and BP control on cardiovascular events by living arrangements among participants with diabetes.

METHODS AND RESULTS

This study included 4731 participants with diabetes in the ACCORD-BP (Action to Control Cardiovascular Risk in Diabetes-Blood Pressure) trial. They were randomized into 4 study arms, each with glycated hemoglobin target (intensive, <6.0% versus standard, 7.0-7.9%) and systolic BP target (intensive, <120 mm Hg versus standard <140 mm Hg). Cox proportional hazard models were used to estimate the joint effect of intensive glycemic and BP control on the composite cardiovascular outcome according to living arrangements. At a mean follow-up of 4.7 years, the cardiovascular outcome was observed in 445 (9.4%) participants. Among participants living with others, intensive treatment for both glycemia and BP showed decreased risk of cardiovascular events compared with standard treatment (hazard ratio [HR], 0.68 [95% CI, 0.51-0.92]). However, this association was not found among participants living alone (HR, 0.96 [95% CI, 0.58-1.59]). for interaction between intensive glycemic and BP control was 0.53 among participants living with others and 0.009 among those living alone ( value for 3-way interaction including living arrangements was 0.049).

CONCLUSIONS

We found benefits of combining intensive glycemic and BP control for cardiovascular outcomes among participants living with others but not among those living alone. Our study highlights the critical role of living arrangements in intensive care among patients with diabetes.

摘要

背景

尽管独居或与他人同住是糖尿病心血管预防的一个关键社会因素,但目前缺乏关于强化血糖和血压(BP)控制对不同居住安排的心血管结局影响是否存在差异的证据。因此,我们旨在研究在糖尿病患者中,根据居住安排,强化血糖和 BP 控制对心血管事件的联合作用是否存在异质性。

方法和结果

这项研究纳入了 ACCORD-BP(控制糖尿病心血管风险行动-血压)试验中的 4731 名糖尿病患者。他们被随机分配到 4 个研究组,每组的糖化血红蛋白目标(强化组,<6.0%;标准组,7.0-7.9%)和收缩压目标(强化组,<120mmHg;标准组,<140mmHg)不同。采用 Cox 比例风险模型根据居住安排估计强化血糖和 BP 控制对复合心血管结局的联合作用。平均随访 4.7 年后,445 名(9.4%)参与者发生心血管结局。在与他人同住的参与者中,与标准治疗相比,强化血糖和 BP 治疗可降低心血管事件风险(风险比[HR],0.68[95%可信区间,0.51-0.92])。然而,在独居的参与者中,这种关联并不存在(HR,0.96[95%可信区间,0.58-1.59])。对于与他人同住的参与者,强化血糖和 BP 控制之间的交互作用检验值为 0.53,而独居的参与者则为 0.009(包括居住安排的 3 项交互作用检验值为 0.049)。

结论

我们发现,对于与他人同住的参与者,联合强化血糖和 BP 控制对心血管结局有益,但对于独居的参与者则无此获益。我们的研究强调了居住安排在糖尿病患者强化治疗中的关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecae/11255686/e1cc8e7912d3/JAH3-13-e033860-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecae/11255686/0a6d6d81c93e/JAH3-13-e033860-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecae/11255686/787d7b371add/JAH3-13-e033860-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecae/11255686/e1cc8e7912d3/JAH3-13-e033860-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecae/11255686/0a6d6d81c93e/JAH3-13-e033860-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecae/11255686/787d7b371add/JAH3-13-e033860-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecae/11255686/e1cc8e7912d3/JAH3-13-e033860-g003.jpg

相似文献

1
Heterogeneous Effects of Intensive Glycemic and Blood Pressure on Cardiovascular Events Among Diabetes by Living Arrangements.基于居住安排的糖尿病患者强化血糖和血压控制对心血管事件的异质性影响。
J Am Heart Assoc. 2024 Jul 2;13(13):e033860. doi: 10.1161/JAHA.123.033860. Epub 2024 Jun 27.
2
Long-Term Effects of Intensive Glycemic and Blood Pressure Control and Fenofibrate Use on Kidney Outcomes.强化血糖和血压控制及使用非诺贝特对肾脏结局的长期影响。
Clin J Am Soc Nephrol. 2018 Nov 7;13(11):1693-1702. doi: 10.2215/CJN.06200518. Epub 2018 Oct 25.
3
Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT.强化收缩压降压治疗对标准血糖控制的 2 型糖尿病患者及无糖尿病患者心血管事件和死亡率的影响:来自 ACCORD BP 和 SPRINT 的结果再分析。
J Am Heart Assoc. 2018 Sep 18;7(18):e009326. doi: 10.1161/JAHA.118.009326.
4
Benefits of Intensive Blood Pressure Treatment in Patients With Type 2 Diabetes Mellitus Receiving Standard but Not Intensive Glycemic Control.强化降压治疗对接受标准而非强化血糖控制的 2 型糖尿病患者的益处。
Hypertension. 2018 Aug;72(2):323-330. doi: 10.1161/HYPERTENSIONAHA.118.11408. Epub 2018 Jul 2.
5
Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients.联合强化血压和血糖控制并不能为 2 型糖尿病患者的微血管结局带来额外获益。
Kidney Int. 2012 Mar;81(6):586-94. doi: 10.1038/ki.2011.415. Epub 2011 Dec 14.
6
Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial.2型糖尿病合并心血管危险因素管理策略的结局:ACCORD随机试验
Diabetes Care. 2014 Jun;37(6):1721-8. doi: 10.2337/dc13-2334. Epub 2014 Mar 4.
7
The Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering on Cardiovascular Outcomes and All-Cause Mortality in Type 2 Diabetes.基础舒张压对强化降压对 2 型糖尿病心血管结局和全因死亡率影响的影响。
Diabetes Care. 2020 Aug;43(8):1878-1884. doi: 10.2337/dc19-2047. Epub 2020 May 4.
8
Effects of Intensive Glycemic Control on Clinical Outcomes Among Patients With Type 2 Diabetes With Different Levels of Cardiovascular Risk and Hemoglobin A in the ADVANCE Trial.强化血糖控制对 ADVANCE 试验中不同心血管风险和血红蛋白 A 水平的 2 型糖尿病患者临床结局的影响。
Diabetes Care. 2020 Jun;43(6):1293-1299. doi: 10.2337/dc19-1817. Epub 2020 Mar 19.
9
Association of Intensive Blood Pressure Control and Living Arrangement on Cardiovascular Outcomes by Race: Post Hoc Analysis of SPRINT Randomized Clinical Trial.强化血压控制与居住安排对不同种族心血管结局的影响关联:SPRINT 随机临床试验的事后分析。
JAMA Netw Open. 2022 Mar 1;5(3):e222037. doi: 10.1001/jamanetworkopen.2022.2037.
10
What matters in ADVANCE and ADVANCE-ON.ADVANCE 和 ADVANCE-ON 中的要点。
Diabetes Obes Metab. 2012 Jan;14 Suppl 1:20-9. doi: 10.1111/j.1463-1326.2011.01509.x.

本文引用的文献

1
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2023.9. 血糖治疗的药物学方法:2023 年糖尿病的护理标准。
Diabetes Care. 2023 Jan 1;46(Suppl 1):S140-S157. doi: 10.2337/dc23-S009.
2
Association of Intensive Blood Pressure Control and Living Arrangement on Cardiovascular Outcomes by Race: Post Hoc Analysis of SPRINT Randomized Clinical Trial.强化血压控制与居住安排对不同种族心血管结局的影响关联:SPRINT 随机临床试验的事后分析。
JAMA Netw Open. 2022 Mar 1;5(3):e222037. doi: 10.1001/jamanetworkopen.2022.2037.
3
The American Heart Association 2030 Impact Goal: A Presidential Advisory From the American Heart Association.
美国心脏协会 2030 年影响目标:美国心脏协会主席顾问倡议
Circulation. 2020 Mar 3;141(9):e120-e138. doi: 10.1161/CIR.0000000000000758. Epub 2020 Jan 29.
4
Living alone is associated with all-cause and cardiovascular mortality: 32 years of follow-up in the Copenhagen Male Study.独居与全因和心血管死亡率相关:哥本哈根男性研究 32 年随访。
Eur Heart J Qual Care Clin Outcomes. 2019 Jul 1;5(3):208-217. doi: 10.1093/ehjqcco/qcz004.
5
Social Determinants of Risk and Outcomes for Cardiovascular Disease: A Scientific Statement From the American Heart Association.心血管疾病风险与预后的社会决定因素:美国心脏协会科学声明
Circulation. 2015 Sep 1;132(9):873-98. doi: 10.1161/CIR.0000000000000228. Epub 2015 Aug 3.
6
Retrospective analysis of long-term adherence to and persistence with DPP-4 inhibitors in US adults with type 2 diabetes mellitus.美国2型糖尿病成年患者对二肽基肽酶-4(DPP-4)抑制剂长期依从性和持续性的回顾性分析。
Adv Ther. 2014 Dec;31(12):1287-305. doi: 10.1007/s12325-014-0171-3. Epub 2014 Dec 12.
7
Adherence to diabetes medication: a systematic review.糖尿病药物治疗的依从性:一项系统综述。
Diabet Med. 2015 Jun;32(6):725-37. doi: 10.1111/dme.12651. Epub 2015 Jan 9.
8
Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial.2型糖尿病合并心血管危险因素管理策略的结局:ACCORD随机试验
Diabetes Care. 2014 Jun;37(6):1721-8. doi: 10.2337/dc13-2334. Epub 2014 Mar 4.
9
Association of national initiatives to improve cardiac arrest management with rates of bystander intervention and patient survival after out-of-hospital cardiac arrest.国家改善心脏骤停管理举措与院外心脏骤停后旁观者干预和患者生存之间的关联。
JAMA. 2013 Oct 2;310(13):1377-84. doi: 10.1001/jama.2013.278483.
10
Living alone and risk of cardiovascular events following discharge after acute myocardial infarction in Japan.在日本,急性心肌梗死后出院独居与心血管事件风险增加相关。
J Cardiol. 2013 Oct;62(4):257-62. doi: 10.1016/j.jjcc.2013.04.009. Epub 2013 Jun 15.